Alpha 2.0
Login Register
» Authors » L P Koh

L P Koh

Explore the profile of L P Koh including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 88
Followers 0
Related Specialties
General Medicine
Hematology
General Surgery
Top 10 Co-Authors
Y T Goh
Y C Linn
P H C Tan
P Tan
H J Ng
W Y K Hwang
L C Lim
C T H Chuah
D Tan
K Devendra
Published In
Ann Acad Med Singap
Bone Marrow Transplant
Ann Hematol
Br J Haematol
Br J Dermatol
Affiliations
Soon will be listed here.
Recent Articles
1.
Role of upfront autologous transplant for peripheral T-cell lymphoma patients achieving a complete remission with first-line therapy: a systematic review and meta-analysis
Girard L, Koh Y, Koh L, Chee Y, Chan H, Lee J, et al.
Bone Marrow Transplant . 2024 Mar; 59(6):838-848. PMID: 38443704
There is currently no consensus on the role of upfront autologous transplantation (ASCT) for patients with peripheral T-cell lymphomas (PTCL), especially in patients achieving first complete remission (CR1) following chemotherapy,...
2.
Free satellite data key to conservation
Buchanan G, Beresford A, Hebblewhite M, Escobedo F, De Klerk H, Donald P, et al.
Science . 2018 Jul; 361(6398):139-140. PMID: 30002246
No abstract available.
3.
Safety and cost-effectiveness of outpatient autologous transplantation for multiple myeloma in Asia: single-center perspective from Singapore
Abid M, Christopher D, Abid M, Poon M, Tan L, Koh L, et al.
Bone Marrow Transplant . 2017 May; 52(7):1044-1046. PMID: 28481354
No abstract available.
4.
Early relapse post autologous transplant is a stronger predictor of survival compared with pretreatment patient factors in the novel agent era: analysis of the Singapore Multiple Myeloma Working Group
Ong S, de Mel S, Chen Y, Ooi M, Surendran S, Lin A, et al.
Bone Marrow Transplant . 2016 Mar; 51(7):933-7. PMID: 26974274
The clinical outcome of multiple myeloma is heterogeneous. Both the depth of response to induction and transplant as well as early relapse within a year are correlated with survival, but...
5.
Successful treatment of isohemagglutinin-mediated pure red cell aplasia after ABO-mismatched allogeneic hematopoietic cell transplant using bortezomib
Poon L, Koh L
Bone Marrow Transplant . 2011 Aug; 47(6):870-1. PMID: 21874058
No abstract available.
6.
Leucoderma in chronic graft-versus-host disease: excellent repigmentation with noncultured cellular grafting
Tan A, Koh L, Goh B
Br J Dermatol . 2011 Apr; 165(2):435-7. PMID: 21457204
No abstract available.
7.
Allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia following nonmyeloablative conditioning using 200-cGy total body irradiation and fludarabine
Koh L, Koh M, Ng H, Hwang W, Goh Y, Linn Y, et al.
Biol Blood Marrow Transplant . 2006 Jul; 12(8):887-90. PMID: 16864060
No abstract available.
8.
Successful treatment of primary granulocytic sarcoma by non-myeloablative stem cell transplant
Tan D, Wong G, Koh L, Hwang W, Loh Y, Linn Y, et al.
Leuk Lymphoma . 2005 Dec; 47(1):159-62. PMID: 16321843
Pre-leukemic granulocytic sarcoma (GS) may pose an initial diagnostic problem and its therapeutic approach has never been formally established. To our knowledge, non-myeloablative stem cell transplantation has been reported in...
9.
Severe conidiobolomycosis complicating induction chemotherapy in a patient with acute lymphoblastic leukaemia
Tan D, Hsu L, Koh L, Goh Y, Koh M
Br J Haematol . 2005 May; 129(4):447. PMID: 15877726
No abstract available.
10.
In vitro biological characteristics of human cord blood-derived megakaryocytes
Sun L, Tan P, Yap C, Hwang W, Koh L, Lim C, et al.
Ann Acad Med Singap . 2004 Nov; 33(5):570-5. PMID: 15531951
Introduction: Umbilical cord blood (CB) has been used as an alternative source for haematopoietic stem cell transplantation (HSCT) in recent years. However, delayed platelet recovery is frequently associated with CB...